JYNNEOS疫苗接种对mopox临床进展的影响:一个病例控制研究
Lauren Granskog1, Kayla Saadeh2, Kieran Lorenz2
1STD Control Branch, California Department of Public Health, Richmond, CA, USA; School of Public Health, University of California, Berkeley, CA, USA.
The Lancet. Infectious diseases
|May 24, 2025
概括
暴露前的JYNNEOS疫苗接种显著降低了mopox的严重程度,降低了传播病变和住院的风险. 对接种疫苗的人群中较轻的症状的认识对于准确的mpox诊断至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
- 公共卫生监督 公共卫生监督
背景情况:
- 吉尼奥斯疫苗对mpox (病毒) 有效.
- 对疫苗对MPOX疾病严重程度的影响的理解有限.
- 该研究旨在评估mpox患者的临床特征和疫苗接种状态.
研究的目的:
- 评估JYNNEOS疫苗在预防严重mopox结果方面的有效性.
- 调查疫苗接种和mopox临床表现之间的关联.
- 评估疫苗对病变传播,住院和前期症状的影响.
主要方法:
- 使用加利福尼亚州mopox监测数据的病例控制研究.
- 包括实验室确认的mopox和完整的损伤部位数据的 cisgender男性.
- 病例 (扩散性病变) 和对照病例 (局部病变) 之间的疫苗接种状态比较.
- 估计的疫苗有效性,防止进展到传播性病变,住院,和前兆症状.
主要成果:
- 暴露前的JYNNEOS疫苗接种显示了58.8%的抗疾病进展的有效性.
- 暴露后接种疫苗的有效率为15.9%.
- 暴露前的疫苗接种显著降低了住院风险 (85.4%) 和前兆症状.
- 疗效因艾滋病毒状况而异,艾滋病毒阴性个体的保护性更高.
结论:
- 暴露前的JYNNEOS疫苗接种与 cisgender男性中较不严重的 mpox 疾病有关.
- 接种疫苗的个体可能会出现局部病变和较少的前兆症状.
- 识别减弱的mopox表型对于在接种疫苗的人群中进行准确诊断至关重要.
相关概念视频
Bias in Epidemiological Studies
713
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
713
Confounding in Epidemiological Studies
280
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
280
Vaccinations
45.4K
Overview
45.4K
Prevalence and Incidence
842
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
842
Cancer Vaccines
523
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
523
Antimicrobial Effectiveness
179
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
179


